Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_assertion description "[Antisense oligonucleotides (oligos) directed against mRNA-encoding, transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR), have been shown to significantly inhibit in vitro and in vivo growth of prostate tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_assertion evidence source_evidence_literature NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_assertion SIO_000772 12616956 NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_assertion wasDerivedFrom befree-2016 NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_assertion wasGeneratedBy ECO_0000203 NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP385627.RAKBciLoyTwG_sFTlwZ5Tz8Mp4HuDYhTExP6ZjecgZlWQ130_provenance.